Our previous findings demonstrated that restoring sGC function inhibits the growth of glioma and normalizes cellular architecture [6], and the results of the present study suggest that a prodifferentiation mechanism is involved in sGC-targeted therapy and may be used as an approach alternative to various toxic treatments, such as chemotherapy and radiation. Here, SGCB is linked to central nervous system cancer.